Nab-Paclitaxel Does Not Increase Overall Survival in Biliary Tract Cancer

MONDAY, Jan. 23, 2023 (HealthDay News) -- For patients with biliary tract cancer (BTC), no significant improvement is observed in overall survival with the addition of albumin-bound paclitaxel to gemcitabine and cisplatin (GAP) versus gemcitabine/cisplatin (GC), according to a study presented at the American Society of Clinical Oncology annual Gastrointestinal Cancers Symposium, held from Jan. 19 to 21 in San Francisco.
Rachna T. Shroff, M.D., from the University of Arizona in Tucson, and colleagues conducted a randomized phase III trial comparing GAP to GC among newly diagnosed advanced BTC patients. A total of 441 patients (73 percent with metastases) were randomly assigned in a 2:1 ratio to either GAP or GC and were treated until progression.
The researchers found that the median overall survival was 14 and 12.7 months for GAP and GC, respectively (hazard ratio, 0.93; 95 percent confidence interval, 0.74 to 1.19; P = 0.58); the overall response rate (confirmed and nonconfirmed) was 34 and 25 percent, respectively (P = 0.11), and median progression-free survival was 8.2 and 6.4 months, respectively (hazard ratio, 0.92; 95 percent confidence interval, 0.72 to 1.16; P = 0.47). In exploratory subset analyses, overall survival was improved with GAP versus GC in patients with locally advanced disease (median, 19.2 versus 13.7 months; hazard ratio, 0.67; 95 percent confidence interval, 0.42 to 1.06; P = 0.09) and in patients with gallbladder adenocarcinoma (median, 17.0 versus 9.3 months; hazard ratio, 0.74; 95 percent confidence interval, 0.41 to 1.35; P = 0.33).
"While the addition of nab-paclitaxel did not improve survival, the triplet may merit further investigation in locally advanced biliary cancers as a potential neoadjuvant approach," Shroff said in a statement.
The study was partially funded by Celgene, a subsidiary of Bristol Myer Squibb, the manufacturer of nab-paclitaxel.
Related Posts
Un estudio con camisetas muestra la importancia del olor de mamá para vincularse con el bebé
LUNES, 13 de diciembre de 2021 (HealthDay News) -- El sonido de la voz de mamá...
Pfizer Says New COVID-19 Pill Cuts Severe Disease by 89 Percent
FRIDAY, Nov. 5, 2021 (HealthDay News) -- Pfizer Inc. announced Friday that its...
Unos devastadores tornados dejan peligros a su paso: consejos para mantenerse seguro
MARTES, 4 de abril de 2023 (HealthDay News) -- Los tornados conllevan muchos...
Menus With ‘Climate Change Impact’ Info Sway Diners’ Choices
THURSDAY, Dec. 29, 2022 (HealthDay News) -- Adding climate-impact labeling to...
